Clinical Trial Update: Trial of IRE in Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for irreversible electroporation (IRE) in cholangiocarcinoma has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• IRE (irreversible electroporation) (irreversible electroporation)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cholangiocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-10